NDC 49884-160-52 - Everolimus

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
49884-160
Requested NDC
49884-160-52
Package NDCs from labels
49884-160-52, 49884-160-02
Manufacturer
Par Health USA, LLC
Effective date
2026-10-07
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Everolimus - Par Health USA, LLCPar Health USA, LLC2026-10-07HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
49884-160-02Everolimus6 in 1 CARTONTABLET615
49884-160-52Everolimus10 in 1 BLISTER PACKTABLET1015

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
49884-160EVEROLIMUS TABLET [ENDO USA, INC.]13Legacy NDC, 2 package rows20240802_59cb86d5-8706-4619-b074-af253d3e0b68.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
49884-160-02EA - Each49884-16039ec7237-0b5c-46e4-939c-3c601f3db48f12023-01-09
49884-160-52EA - Each49884-1606bbbd274-83b2-4116-a540-a222391a163912023-01-09

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 27 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
everolimusEVEROLIMUSAurobindo Pharma Limited43ef3c29-0e25-4fdd-aea1-06a20af9bbab2026-10-09Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2056895
rxcui: 977427
rxcui: 977434
rxcui: 977438
unii: 9HW64Q8G6G
EverolimusEVEROLIMUSPar Health USA, LLC59cb86d5-8706-4619-b074-af253d3e0b682026-10-07Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA205775
ndc (package): 49884-158-02
ndc (package): 49884-283-52
ndc (package): 49884-160-02
ndc (package): 49884-158-52
ndc (package): 49884-283-02
ndc (package): 49884-159-52
ndc (package): 49884-159-02
ndc (package): 49884-160-52
ndc (product): 49884-158
ndc (product): 49884-160
ndc (product): 49884-159
ndc (product): 49884-283
ndc11 (package): 49884016052
rxcui: 2056895
rxcui: 977427
rxcui: 977434
rxcui: 977438
spl id: 7523ed83-6f81-4cc8-b815-e646ffa1dd80
spl set id: 59cb86d5-8706-4619-b074-af253d3e0b68
unii: 9HW64Q8G6G
EverolimusEVEROLIMUSHikma Pharmaceuticals USA Inc.cf2dd54b-7a1d-4401-9a01-75e68235e4332026-09-25Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 9HW64Q8G6G
EverolimusEVEROLIMUSANI Pharmaceuticals, Inc.ed7f01b0-3660-4785-a057-a32eea78d64b2026-09-24Warnings, Adverse reactionsExact identifier
unii: 9HW64Q8G6G
ZortressEVEROLIMUSNovartis Pharmaceuticals Corporatione082a024-7850-400b-a5c2-2a140612562a2026-09-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2056895
rxcui: 977427
rxcui: 977434
rxcui: 977438
unii: 9HW64Q8G6G
EverolimusEVEROLIMUSHikma Pharmaceuticals USA Inc.5aaf2fb7-93f6-40d6-941a-9583a3794ce72026-08-14Warnings, Adverse reactionsExact identifier
unii: 9HW64Q8G6G
EverolimusEVEROLIMUSi3 Pharmaceuticals, LLCbe5da0fd-8fd4-4f84-a307-f270048d503c2026-07-29Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2056895
rxcui: 977427
rxcui: 977434
rxcui: 977438
unii: 9HW64Q8G6G
EverolimusEVEROLIMUS TABLETSBreckenridge Pharmaceutical, Inc.c7bb6ba1-9a7f-43f5-b058-ef26d4b592212026-07-06Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2056895
rxcui: 977427
rxcui: 977434
rxcui: 977438
unii: 9HW64Q8G6G
EVEROLIMUSEVEROLIMUSBiocon Pharma Inc.5fb55800-f322-6bb6-9dde-622925ef28bd2026-06-30Warnings, Adverse reactionsExact identifier
unii: 9HW64Q8G6G
EverolimusEVEROLIMUSBiocon Pharma Inc.5b809dfe-c076-07c5-207e-178c3f0d32d32026-06-30Warnings, Adverse reactionsExact identifier
unii: 9HW64Q8G6G
EVEROLIMUSEVEROLIMUSAmneal Pharmaceuticals NY LLC6f1ae129-c21e-4c25-84c1-a6757d9a7eb22026-06-16Warnings, Adverse reactionsExact identifier
unii: 9HW64Q8G6G
TORPENZEVEROLIMUSUpsher-Smith Laboratories, LLC4c0075dd-a0a8-4dc4-be32-1be8383fbbdc2026-06-10Warnings, Adverse reactionsExact identifier
unii: 9HW64Q8G6G
AfinitorEVEROLIMUSNovartis Pharmaceuticals Corporation2150f73a-179b-4afc-b8ce-67c85cc72f042026-06-01Warnings, Adverse reactionsExact identifier
unii: 9HW64Q8G6G
YulithiraEVEROLIMUSCivicaScript, LLC5e325efa-8ae6-4dac-b59b-d7c74c73186c2026-03-31Warnings, Adverse reactionsExact identifier
unii: 9HW64Q8G6G
everolimusEVEROLIMUSNovugen Pharma (USA) LLC.67e62e26-448d-46ec-b5a1-00dc1b5e26c62026-03-10Warnings, Adverse reactionsExact identifier
unii: 9HW64Q8G6G
EverolimusEVEROLIMUSAscend Laboratories, LLC2693c497-a70b-4d00-b6db-602c872e5bed2025-12-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2056895
rxcui: 977427
rxcui: 977434
rxcui: 977438
unii: 9HW64Q8G6G
EverolimusEVEROLIMUSNatco Pharma Limitedd44998bb-5deb-4ee7-a0a5-979fe3f495572025-10-14Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2056895
rxcui: 977427
rxcui: 977434
rxcui: 977438
unii: 9HW64Q8G6G
EverolimusEVEROLIMUSBreckenridge Pharmaceutical, Inc.01f7b5fb-be0d-4adf-acd2-6899018de9662025-09-05Warnings, Adverse reactionsExact identifier
unii: 9HW64Q8G6G
EverolimusEVEROLIMUSBiocon Pharma Inc.435da284-ef0e-ca90-e0db-bab9382922e02025-05-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2056895
rxcui: 977427
rxcui: 977434
rxcui: 977438
unii: 9HW64Q8G6G
Multi-PhenolicMANNOSE, 5-HYDROXYTRYPTOPHAN, ACETALDEHYDE, ACETYLCHOLINE CHLORIDE, ASCORBICUM ACIDUM, ASPARTAME, BUTYLATED HYDROXYTOLUENE, CAFFEIC ACID, CANDIDA ALBICANS, CINNAMIC ACID, CONIFERYL ALCOHOL, COUMARINUM, DOPAMINE HYDROCHLORIDE, ESTRADIOL, GABA (GAMMA-AMINOBUTYRIC ACID), GALLICUM ACIDUM, HISTAMINUM HYDROCHLORICUM, HYDROCORTISONE, INDOLUM, L-DOPA, L-PHENYLALANINE, MELATONIN, MENADIONE, NOREPINEPHRINE (BITARTRATE), PETROSELINUM CRISPUM, PHENYL ISOTHIOCYANATE, PIPERINE, PROGESTERONE, PYRROLE, QUERCETIN,Energique, Inc.492b412a-01cc-48f2-bcdc-6fffcc6519632024-08-23WarningsExact identifier
unii: 1P9D0Z171K

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.